About 57 Trademarks found for “hy*la”

The wording HYOUBALA has no meaning in a foreign language.

Ocular pharmaceuticals; ophthalmic and ophthalmological preparations; pharmaceutical products for ophthalmological use; solutions for lubrication and rewetting the eyes; eye drops; solutions for ocular hydration; solutions for reducing ocular inflammation and pain associated with ocular surgery and other pathologies; solutions for reducing symptoms associated with conjunctivitis; pharmaceutical preparations for the prevention and treatment of eye disorders, diseases and conditions; solutions and preparations for treating pathologies of the eyelids and eyelid margins; pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists

Bath mats; Artificial turf; Bags specially adapted for yoga mats; Beach mats; Carpet underlay; Carpeting for vehicles; Carpets, rugs, mats and matting, linoleum for covering existing floors; Cloth wall coverings; Decorative wall hangings, not of textile; Floor coverings; Floor mats for automobiles; Floor mats for vehicles; Gymnasium exercise mats; Gymnastic mats; Meditation mats; Non-textile wall coverings; Non-textile wall hangings; Pet feeding mats; Plastic bath mats; Plastic wallpaper; Prayer mats; Tatami mats; Wall hangings, not of textile; Wallpaper; Wallpaper with 3D visual effects; Wallpapers; Yoga towels specially adapted for yoga mats

Fuel, namely, liquid fuel and gaseous fuel; fuel for motor vehicles and for fuel cell vehicles, namely, liquid and gaseous fuel; hydrogen fuel

Collection of portable electronic devices for the purpose of recycling, refurbishing and repair; refurbishing and repair of portable electronic devices for others

Pharmaceutical preparations for cardiovascular diseases, illnesses, and conditions; Pharmaceutical preparations for infusion conditions; pharmaceutical preparations for cardiovascular conditions and blood conditions, namely, novel, plasma derived apolipoprotein A-I conditions while undergoing infusion therapy; pharmaceutical preparations for novel apolipoprotein A-I infusion therapy to potentially reduce the risk of recurrent major adverse cardiovascular events (MACE) in patients within 90 days of an acute myocardial infarction (AMI) with a sustained benefit for 365 days; Pharmaceutical preparations for acute myocardial infarction (AMI); Pharmaceutical preparations for cardiovascular diseases; pharmaceutical preparations for treating von Willebrand disease, hemophilia, primary immunodeficiency, hereditary angioedema, fibrinogen deficiency, Alpha 1 antitrypsin deficiency, and inflammatory demyelinating polyneuropathy; Pharmaceutical preparations for the treatment and prevention of blood and bleeding disorders; pharmaceutical preparations for the treatment of hemophilia; pharmaceutical products derived from recombinant DNA technology for the treatment of hemophilia, namely, pharmaceutical preparations derived from recombinant DNA technology for the treatment of hemophilia; pharmaceutical preparations and substances for the treatment of blood disorders; pharmaceutical preparations for the treatment of blood conditions, respiratory conditions, pneumonia, covid-19, and influenza; Pharmaceutical preparations, namely, antibody for the treatment of acute respiratory distress syndrome, ARDS; pharmaceutical preparations, namely, antibody for the treatment of Idiopathic Pulmonary Fibrosis, IPF and Interstitial Lung Diseases, ILD; Pharmaceutical preparations, namely, antibody for the treatment of Hereditary Angioedema, HAE; Pharmaceutical preparations, namely, for the treatment of Hereditary Angioedema, HAE, respiratory diseases, acute respiratory distress syndrome, ARDS, Idiopathic Pulmonary Fibrosis, IPF and Interstitial Lung Diseases, ILD

vacuum cleaners

Vehicle fueling services; vehicle refueling services; filling services for motor vehicles and fuel cell vehicles, namely, vehicle fueling services for fuel cell vehicles; fueling of hydrogen gas for vehicles

Collagen for industrial purposes; Protein in raw material form for scientific and medical research; Proteins for use in manufacture; Proteins for use in the manufacture of food supplements; Proteins for the food industry

The mark consists of the stylized wording "HYMELA".